RECURSION PHARMACEUTICALS, INC. — Director's Dealing 2026

Feb 20, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK: 0001601830
Period of Report: 2026-02-17

Reporting Person: Gibson Christopher (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-17	Class A Common Stock	F	27265	$3.49	Disposed	906556	Direct
2026-02-19	Class A Common Stock	C	40000	—	Acquired	946556	Direct
2026-02-19	Class A Common Stock	S	40000	$3.46	Disposed	906556	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-19	Class B Common Stock	$0	C	40000	Disposed		Class A Common Stock (40000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Class B Common Stock	$0		Class A Common Stock (0)	386000	Indirect
Class B Common Stock	$0		Class A Common Stock (0)	388000	Indirect
Class B Common Stock	$0		Class A Common Stock (0)	50000	Indirect
Stock Option (Right to Buy)	$7.25	2035-02-03	Class A Common Stock (0)	1050567	Direct
Stock Option (Right to Buy)	$10.09	2034-02-09	Class A Common Stock (0)	666898	Direct
Stock Option (Right to Buy)	$8.55	2033-02-01	Class A Common Stock (0)	813600	Direct
Stock Option (Right to Buy)	$11.40	2032-02-04	Class A Common Stock (0)	399002	Direct
Stock Option (Right to Buy)	$11.40	2032-02-04	Class A Common Stock (0)	5436	Direct
Stock Option (Right to Buy)	$2.48	2030-12-30	Class A Common Stock (0)	282500	Direct

Footnotes

F1: Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.

F2: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F3: This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.

F4: The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.

F5: The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.

F6: The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.

F7: The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.

F8: The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.

F9: The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.

F10: The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.

F11: The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.